PEF failed to consistently reflect FEV1 improvements after bronchodilation, indicating that handheld spirometry may better ...

Tozorakimab, an anti-IL-33 antibody, improves lung function and may reduce exacerbations in high-risk COPD patients, early ...

Jeremy Derozin is the fifth trainer from AQHA's Top 10 earnings list in 2024 to be sidelined for a positive test of the ...

Kenvue and API launch India's first Cough Clinics to improve cough diagnosis and treatment. The initiative aims to address ...

Kenvue, a consumer health company and makers of Benadryl cough syrup, on Friday announced the launch of 'Cough Clinics', an ...

Astegolimab from Roche's Genentech fails phase 3 COPD trial, reflecting challenges in monoclonal antibody treatment for the ...

Benadryl maker Kenvue partners with the Association of Physicians of India to open Centres of Excellence for clinical ...

A common asthma inhaler has been recalled in the UK due to a labelling error that could mislead patients about their dosage.

Fractional exhaled Nitric Oxide (FeNO) is widely used in both primary and secondary care settings across the world. Many ...

We recently published 10 Stocks Exploded Over 100%; One Shockingly Soared 11,000%. Verona Pharma plc (NASDAQ:VRNA) is one of ...

Our Bureau, Mumbai Monday, July 21, 2025, 17:15 Hrs [IST] ...

The UK's drug watchdog has issued an urgent recall of a widely prescribed asthma inhaler following the discovery of a serious ...